- Perry Disease: Concept of a New Disease and Clinical Diagnostic Criteria
-
Yoshio Tsuboi, Takayasu Mishima, Shinsuke Fujioka
-
J Mov Disord. 2021;14(1):1-9. Published online September 21, 2020
-
DOI: https://doi.org/10.14802/jmd.20060
-
-
6,396
View
-
353
Download
-
5
Citations
-
 Abstract
 PDF
- Perry disease is a hereditary neurodegenerative disease with autosomal dominant inheritance. It is characterized by parkinsonism, psychiatric symptoms, unexpected weight loss, central hypoventilation, and transactive-response DNA-binding protein of 43kD (TDP-43) aggregation in the brain. In 2009, Perry disease was found to be caused by dynactin I gene (DCTN1), which encodes dynactin subunit p150 on chromosome 2p, in patients with the disease. The dynactin complex is a motor protein that is associated with axonal transport. Presently, at least 8 mutations and 22 families have been reported; other than the “classic” syndrome, distinct phenotypes are recognized. The neuropathology of Perry disease reveals severe degeneration in the substantia nigra and TDP-43 inclusions in the basal ganglia and brain stem. How dysfunction of the dynactin molecule is related to TDP-43 pathology in Perry disease is important to elucidate the pathological mechanism and develop new treatment.
-
Citations
Citations to this article as recorded by  - Extubation failure due to atypical parkinsonism with negligible motor and variable non-motor symptoms associated with a variant of DCTN1
Hidetada Yamada, Shuichiro Neshige, Hiroyuki Morino, Hirofumi Maruyama
Internal and Emergency Medicine.2023; 18(1): 329. CrossRef - Monogenic Parkinson’s Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing
Fangzhi Jia, Avi Fellner, Kishore Raj Kumar
Genes.2022; 13(3): 471. CrossRef - Perry disease in an Argentine family due to the DCTN1 p.G67D variant
Emanuel Silva, Tatiana Itzcovich, Matías Niikado, Alejandro Caride, Elmer Fernández, Juan Carlos Vázquez, Leonardo Romorini, Mariela Marazita, Gustavo Sevlever, Horacio Martinetto, Ezequiel I. Surace
Parkinsonism & Related Disorders.2022; 97: 63. CrossRef - Clinical, pathological and genetic characteristics of Perry disease—new cases and literature review
Jarosław Dulski, Catalina Cerquera‐Cleves, Lukasz Milanowski, Alexa Kidd, Emilia J. Sitek, Audrey Strongosky, Ana María Vanegas Monroy, Dennis W. Dickson, Owen A. Ross, Jolanta Pentela‐Nowicka, Jarosław Sławek, Zbigniew K. Wszolek
European Journal of Neurology.2021; 28(12): 4010. CrossRef - Behavioral profile in a Dctn1G71A knock-in mouse model of Perry disease
Manami Deshimaru, Takayasu Mishima, Takuya Watanabe, Kaori Kubota, Mana Hosoi, Mariko Kinoshita-Kawada, Junichi Yuasa-Kawada, Maiko Ikeda, Masayoshi Mori, Yusuke Murata, Takaya Abe, Munechika Enjoji, Hiroshi Kiyonari, Shohta Kodama, Shinsuke Fujioka, Kats
Neuroscience Letters.2021; 764: 136234. CrossRef
|
KMDS
E-submission
